APR a beauty-tech company APR announced today that it filed for a preliminary review on the Korea Exchange (KRX) on September 22. Shinhan Securities is the lead underwriter and Hana Securities is the co-underwriter. With the application, APR begins its full-scale preparation for its initial public offering (IPO). After the application is approved, the company will submit the prospectus. Then, through demand prediction, subscription, and other steps, it will go public on the main KOSPI market early next year. Established in October 2014, APR is a global beauty-tech company performing in Korea a
Image: CDPP by QueryPie & CNAPP by Orca Security CHEQUER Inc., the provider of the cloud solution QueryPie, announced on Sep 11, 2023, that it will participate in ISEC 2023, Asia's largest security event, which will take place at COEX from September 19th to 20th, 2023. ISEC 2023 is a cybersecurity conference aimed at raising awareness of cybersecurity, a key element of digital transformation, with participation from 200 organizations and companies from 20 countries. CHEQUER will host a joint booth with its partner Orca Security, which signed a partnership in June. In particular, CHEQUER’s
Apollon Inc., a medtech startup based in Seoul, will collaborate with the Laser Biomedical Research Center (LBRC) at the Massachusetts Institute of Technology (MIT) with the aim of developing and conducting clinical trials of non-invasive CGMs using Raman spectroscopy for the next two years. Dr. Peter So, Professor of Mechanical and Biological Engineering and Director of the MIT LBRC, and Dr. Jeonwoong Kang of the Department of Mechanical Engineering will lead the collaboration. As a result of Apollon's expertise in Raman diagnostics and spectrometer miniaturization, MIT will invite Dr. Youngk
Gridwiz, a Korea-based energy clean-tech company, announced the successful validation of its V2G (Vehicle to Grid) charging technology through the Smart Green Industrial Complex-Microgrid Project. An industrial complex in Changwon, Korea, is used as the project base to test whether electricity could be supplied to customers by leveraging hydrogen fuel cells, photovoltaic power, and other clean energy sources along with chargers and EV resources with ESS and V2G capabilities, without relying on utility power. As a project participant, Gridwiz’s role is to build and operate V2G charging stations
Adler's 3D gallery in NYC Times Square reflects messages typed on mobile. Pioneering 3D startup, Adler Inc., showcased their real-time 3D advertisement in New York Times Square from May 8th to 14th. Adler's 3D gallery in NYC Times Square reflects messages typed on mobile. In Times Square, visitors scanned a QR code on the billboard to project their personalized messages in real-time 3D space. Over 67,000 messages were displayed, including personal names and heartfelt tributes to beloved icons. Adler’s free advertising solution enables users to freely share their messages, without having to spe
photo : LiDAR built-in car lamp developed by SOSLAB and SL Corporation SOSLAB, a global leader of 3D high-performance LiDAR hardware and software technologies, and SL Corporation (KRX:005850), a global automotive lamps manufacturer, announced that they had entered into a technology development contract for the core LiDAR technologies and products with a goal of mass production. Through distribution of its LiDAR hardware and software system parts, SOSLAB will provide autonomous driving and state-of-the-art safety functions for SL Corporation’s automotive lamps. Based on the functions, SL Corpor
photo : A digital garment made in CLO and powered by Unreal Engine CLO Virtual Fashion, a global leader in digital garment solutions and the developer of CLO and Marvelous Designer, and Epic Games, the developer of Unreal Engine, today announced that the companies have purchased shares in each other. “We strongly believe that digital garments will play a significant role in the future of digital entertainment and metaverse platforms,” said Simon Kim, CEO of CLO Virtual Fashion. “We are building toward a future where we imagine the digitization of everything, the convergence of fashion with ent
Oncocross, a Seoul-based AI drug discovery and development biotech, announced the completion of phase 1 global clinical trial of OC514, a treatment targeting sarcopenia and other rare muscular diseases. Phase 1 was conducted in Australia. Sarcopenia, a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength that is often accompanied by age-related issues and cancers, was coded as a specific disease by the CDC and WHO in 2016. Although there are no approved drugs in the market yet, the sarcopenia-related healthcare market is gradually expanding including
Over the Hand, selected for TIPS by the Ministry of SMEs and Startups… Research and development of the virtual platform MASCOZ
Hanyang University’s Digital Healthcare Center and MIT Media Lab Sign MOU to Jointly Develop Proposals for Research Collaborations
Movensys Wins Korean Government Contract to Develop AI-based Integrated Control Platform for Autonomous Mobile Robots
106 West 32nd Street, New York, NY 10001
Copyright ©Tech Seoul All Rights Reserved
UPDATE: July 26, 2024, 04:44 PM
